Canine Influenza Vaccine, H3N2 is recommended for use in healthy dogs 8 weeks of age or older as an aid in the control of disease associated with canine influenza virus H3N2.
Shipping : Perishable
Canine Influenza Vaccine, H3N2 is recommended for use in healthy dogs 8 weeks of age or older as an aid in the control of disease associated with canine influenza virus H3N2. This product license is conditional. Efficacy and potency studies are in progress.
VANGUARD® CIV H3N2 Injectable
Zoetis
Canine Influenza Vaccine, H3N2
KILLED VIRUS
For use by, or under the supervision of, a veterinarian.
CIV
8+ WEEKS
INJECT
FOR EASIER STORAGE & VIEWING
• Pull down on the tab.
• Flip tab out and set bottom tray of vials inside top lid.
This product has been shown to be effective for the vaccination of healthy dogs 8 weeks of age or older against canine influenza (H3N2) virus infection. This product contains canine influenza virus A/Illinois/12191/2015. Duration of immunity has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.
Directions: Shake well. Aseptically administer 1 mL subcutaneously. Healthy dogs should receive 2 doses administered 3 weeks apart. Historically, annual revaccination with this product was recommended. The need for annual booster vaccinations has not been established for this product; consultation with a veterinarian or the manufacturer is recommended.
Precautions: Store at 2°-8°C. Prolonged exposure to higher temperatures may adversely affect potency. Do not freeze. Sterilized syringes and needles should be used to administer this vaccine. Contains gentamicin as preservative. This product has not been tested in pregnant animals. In case of anaphylactoid reaction, administer epinephrine. Do not mix with other products. In case of human exposure, contact a physician.
Canine Influenza Vaccine, H3N2 is recommended for use in healthy dogs 8 weeks of age or older as an aid in the control of disease associated with canine influenza virus H3N2. This product license is conditional. Efficacy and potency studies are in progress.
Directions: Shake well. Aseptically administer 1 mL subcutaneously. Healthy dogs should receive 2 doses administered 3 weeks apart. Historically, annual revaccination with this product was recommended. The need for annual booster vaccinations has not been established for this product; consultation with a veterinarian or the manufacturer is recommended
| Directions | Vaccination of healthy dogs is recommended. Shake well. Aseptically administer 1 mL subcutaneously. Healthy dogs 8 weeks of age and older should receive 2 doses administered 3 weeks apart. Annual revaccination with a single dose is recommended. |
|---|
